195 related articles for article (PubMed ID: 3090516)
1. Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII.
Sultan Y; White GC; Aronstam A; Bosser C; Brackmann HH; Brochier G; Gormsen J; Mariani G; Roberts HR; Scarabin Y
Nouv Rev Fr Hematol (1978); 1986; 28(2):85-9. PubMed ID: 3090516
[TBL] [Abstract][Full Text] [Related]
2. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.
Mariani G; Kroner B;
Haematologica; 2001 Nov; 86(11):1186-93. PubMed ID: 11694405
[TBL] [Abstract][Full Text] [Related]
3. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
[TBL] [Abstract][Full Text] [Related]
4. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
Nilsson IM; Berntorp E; Zettervall O
N Engl J Med; 1988 Apr; 318(15):947-50. PubMed ID: 3127711
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.
Kreuz W; Becker S; Lenz E; Martinez-Saguer I; Escuriola-Ettingshausen C; Funk M; Ehrenforth S; Auerswald G; Kornhuber B
Semin Thromb Hemost; 1995; 21(4):382-9. PubMed ID: 8747701
[TBL] [Abstract][Full Text] [Related]
6. [Suppression of factor VIII inhibitor in children with hemophilia A].
Zenz W; Muntean W
Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of a new factor VIII concentrate in hemophilic children].
Carnelli V; Cultrera S; Simoni L; Pasqui G; Busso B; Bagnato L
Pediatr Med Chir; 1983; 5(3):49-55. PubMed ID: 6417627
[TBL] [Abstract][Full Text] [Related]
8. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
[TBL] [Abstract][Full Text] [Related]
9. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
[TBL] [Abstract][Full Text] [Related]
10. [Improvement in anti-hemophilic preparations and its problems. 3. Treatment of hemophilia patients with inhibitors; induction of immune tolerance by a low or intermediate dose regimen].
Iizuka A
Rinsho Ketsueki; 1988 May; 29(5):640-8. PubMed ID: 3145995
[No Abstract] [Full Text] [Related]
11. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
Landolfi R; de Cristofaro R; Lazzareschi I; Riccardi R; Mariani G
Haematologica; 2000 Oct; 85(10 Suppl):73-4. PubMed ID: 11187877
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
[TBL] [Abstract][Full Text] [Related]
13. Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution.
Smith MP; Spence KJ; Waters EL; Beresford-Webb R; Mitchell MJ; Cuttler J; Alhaq A; Brown SA; Savidge GF
Thromb Haemost; 1999 Jan; 81(1):35-8. PubMed ID: 9974371
[TBL] [Abstract][Full Text] [Related]
14. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII: C (FVIII: C) recovery and half-life after infusion of steam-treated high purity factor VIII concentrate in severe hemophilia A--comparison of one-stage assay, two-stage assay and a chromogenic substrate assay.
Hellstern P; Kiehl R; Miyashita C; Schwerdt H; von Blohn G; Köhler M; Büttner M; Wenzel E
Thromb Haemost; 1986 Dec; 56(3):353-9. PubMed ID: 3105109
[TBL] [Abstract][Full Text] [Related]
16. [Substitutive treatment of hemopjolia A using a new factor VIII concentrate].
Allain JP; Steinbuch M; Meunier L; Muller JY; Soulier JP
Nouv Presse Med; 1976 Apr; 5(16):1047-50. PubMed ID: 1272773
[TBL] [Abstract][Full Text] [Related]
17. Ablation of hemophilic FVIII inhibitors with FVIII priming, cyclophosphamide immune suppression, and rapid tapering of FVIII immune tolerance.
Kobrinsky NL; Sjolander DE; Moser DK; Stegman DA
Am J Hematol; 2004 Jun; 76(2):180-4. PubMed ID: 15164387
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of factor VIII: detection and treatment.
Brettler DB
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A.
Mauser-Bunschoten EP; Rosendaal FR; Nieuwenhuis HK; Roosendaal G; Briët E; van den Berg HM
Thromb Haemost; 1994 Jun; 71(6):703-6. PubMed ID: 7974335
[TBL] [Abstract][Full Text] [Related]
20. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
Berntorp E; Astermark J; Carlborg E
Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]